Joint arthroplasty and infection: Where do we stand?

被引:0
|
作者
Vegari D.N. [1 ]
Parvizi J. [2 ]
机构
[1] Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, Philadelphia, PA 19107
[2] Rothman Institute at Thomas Jefferson University Hospital, Philadelphia
关键词
Antibiotics; Cefazolin; Periprosthetic joint; Skin preparation; Space suits;
D O I
10.1615/JLongTermEffMedImplants.v21.i3.60
中图分类号
学科分类号
摘要
With the field of orthopedic surgery making tremendous advances, no one arena has changed more dramatically then total joint arthroplasty. While this kind of surgery has improved quality of life for many patients, it is not without complications. When they do occur, these complications can be devastating and inflict immense burden on patients and the society. Currently, the rate of periprosthetic joint infection ranges from 0.25% to 2.0%. As the number of total joint arthroplasty procedures is expected to rise considerably, these percentages will impose a financial burden on the field of adult reconstruction. The purpose of our paper is to discuss preventative measures that can be taken to curtail infections, the proper diagnosis of such infections, and the appropriate treatment options. © 2011 by Begell House, Inc.
引用
收藏
页码:225 / 232
页数:7
相关论文
共 50 条
  • [31] Delirium: Where do we stand?
    Pae C.-U.
    Marks D.M.
    Han C.
    Patkar A.A.
    Masand P.
    Current Psychiatry Reports, 2008, 10 (3) : 240 - 248
  • [32] WHERE DO WE STAND WITH PPIS
    WELSH, JS
    AMERICAN PHARMACY, 1979, 19 (12): : 12 - 14
  • [33] Hyperfractionation: Where do we stand?
    BeckBornholdt, HP
    Dubben, HH
    LiertzPetersen, C
    Willers, H
    RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) : 1 - 21
  • [34] WHERE DO WE STAND ON METRIFICATION
    KIRCHER, KF
    DESIGN NEWS, 1969, 24 (02) : 1 - &
  • [35] Tuberculosis: Where do we stand?
    Becx-Bleumink, M
    Broekmans, JF
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1998, 3 (06) : 423 - 424
  • [36] Reflections on "Where Do We Stand?"
    Mccaslin, Richard B.
    CIVIL WAR HISTORY, 2014, 60 (04) : 407 - 408
  • [37] Biomarkers, Where Do We Stand
    Dixit, Vikash
    Sharma, Payal
    Dhage, Atul Dyandeo
    INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) : S165 - S166
  • [38] TUBERCULOSIS - WHERE DO WE STAND
    HOLGUIN, AH
    JOURNAL OF THE AMERICAN COLLEGE OF HEALTH ASSOCIATION, 1968, 17 (02): : 175 - 178
  • [39] QCD - WHERE DO WE STAND
    ALTARELLI, G
    MULTIPARTICLE DYNAMICS 1988, 1988, : 253 - 253
  • [40] Pharmacovigilance: Where do we stand?
    Peethambaran, K.
    Khanwelkar, C. C.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2010, 4 (03) : 2636 - 2637